Elsevier,
Treatment of Skin Disease (Fifth Edition)
Comprehensive Therapeutic Strategies
2018, Pages 764-768
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on scleroderma, a rare multisystem disease characterized by skin fibrosis, autoantibody production, and vascular abnormalities often leading to visceral disease.
Elsevier,
Epigenetics of Stress and Stress Disorders, Volume 31 in Translational Epigenetics, 2022, Pages 137-162
Reviews the literature on the epigenetics of PTSD and interpret findings through the lens of understanding the implications for adverse physical health outcomes. The goal of SDG target is to cover treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders.
The relationship between healthy lifestyles and wellbeing, especially focused on women and pregnancy, continues to grow to understand and determine factors connected to chronic disease and to decrease them. Supports SDG target: 3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births
Elsevier,
The COVID-19 Response: The Vital Role of the Public Health Professional, 2023, Pages 143-154
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by examining the role of social determinants and racism in COVID's inequitable impacts, the burnout of the workforce, and the politicization of the response as major factors that will influence the future of the public health system.
This chapter advances SDGs 3, 4, and 10 by exploring topics with emphasis on the benefits and challenges of talking with youth about race and identity, strategies for coping, and ways that we can help promote racial healing in ourselves and our communities.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing coverage of the clinical syndrome of a primary progressive aphasia (PPA), the demographics of this rare neurodegenerative disease, defining clinical and neuroanatomic characteristics of each PPA variant, disease progression, and behavioral features.
Understanding the genetics of retinoblastoma has enabled clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk. The goal of SDG target 3.d is to strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risk.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing understaning of the genetics of retinoblastoma enabling clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk.
Elsevier,
iPSCs - State of the Science
Volume 16 in Advances in Stem Cell Biology
2022, Pages 197-224
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on the uses of iPSCs in inherited diseases and, particularly, in the case of Gaucher disease (GD).
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information about pituitary adenomas and the complex collection of disorders they produce.
